Categories
ALK Chemotherapy Clinical Trials Lung Cancer Metastatic Non-Small Cell Lung Cancer Patient Stories Radiation Therapy Targeted Therapy Treatments

Living With Incurable Stage 4 ALK+ Lung Cancer: How Stephanie Redefines Hope

Living With Incurable (Not Terminal) Stage 4 ALK+ Lung Cancer: How Stephanie Redefines Hope

When Stephanie was diagnosed with stage 4 ALK-positive lung cancer at 44, she was a busy mom of two teenage daughters, working full time and spending weekends skiing, traveling, and cheering from the sidelines at club sports. The first signs that something was wrong showed up as a stubborn cough after COVID and repeated “pneumonia” diagnoses. Even as she cycled through antibiotics and inhalers, she kept pushing through work and parenting — until she had a coughing spell violent enough to break a rib, which finally sent her to the emergency room.

Interviewed by: Keshia Rice
Edited by: Chris Sanchez

In the hospital, imaging revealed tumors in multiple parts of her body, and a biopsy confirmed non-small cell lung cancer that had already spread, making the diagnosis stage 4. Stephanie, a lifelong nonsmoker living outside a city, had never imagined that lung cancer could be possible for her. Like many, she had absorbed the stigma that lung cancer is an “old person’s” or “smoker’s” disease. Learning that her cancer was driven by an ALK mutation completely shifted that narrative and opened the door to targeted therapy and a very different kind of long-term experience with cancer.

Stephanie K. ALK+ lung cancer

While waiting on genomic testing, Stephanie started chemotherapy. She received the call confirming ALK-positive lung cancer while she was literally in the infusion chair and with an IV already in her arm. Her doctor explained that, in the world of lung cancer, being ALK-positive was considered “good news” because there were effective targeted therapies and active clinical trials. Stephanie chose to enroll in a clinical trial designed to match standard-of-care results with fewer side effects and better protection against brain metastases. She describes that decision as both an act of “paying it forward” and a way to potentially spare herself from harsher side effects.

At home, Stephanie and her husband faced the emotional logistics of sharing the news with their daughters. They first mentioned only that she had lung cancer, intentionally holding off on the stage 4 details until scans began to show real treatment response. Months later, after multiple scans showed shrinking tumors, they sat each daughter down individually to talk about what “incurable but not terminal” would mean for their family. 

Today, one year into treatment, Stephanie describes her cancer as a chronic, managed disease, and herself as an advocate who now centers her time and energy on what matters most: her health, her family, and helping other people living with stage 4 ALK-positive lung cancer feel less alone.

Watch Stephanie’s video and browse the edited transcript of her interview to learn more.

  • Persistent or changing symptoms like a chronic cough or unexplained pain deserve follow-up and imaging, even when they are initially labeled as “just pneumonia” or a lingering infection
  • Lung cancer can affect younger, active nonsmokers; anyone with lungs can develop lung cancer, which is why genomic testing for mutations such as ALK is so important
  • Clinical trials and targeted therapies for ALK-positive lung cancer can offer effective treatment options, sometimes with fewer side effects and additional benefits, like better protection against brain metastases
  • Asking for help from loved ones, care teams, and communities is not a sign of weakness; it is a powerful form of self-advocacy that can make the experience more manageable for both patients and families
  • Stephanie’s transformation includes shifting from a fiercely independent, always-last-on-the-list mom to someone who prioritizes her physical, emotional, and mental health and channels her experience into advocacy and education

  • Name: Stephanie K.
  • Age at Diagnosis:
    • 37
  • Diagnosis:
    • Non-Small Cell Lung Cancer (NSCLC)
  • Staging:
    • Stage 4
  • Mutation:
    • ALK
  • Symptoms:
    • Persistent, intense cough
    • General feeling of sluggishness
  • Treatments:
    • Chemotherapy
    • Targeted therapy through a clinical trial
    • Radiation therapy
Stephanie K. ALK+ lung cancer
Stephanie K. ALK+ lung cancer
Stephanie K. ALK+ lung cancer
Stephanie K. ALK+ lung cancer
Stephanie K. ALK+ lung cancer
Stephanie K. ALK+ lung cancer
Stephanie K. ALK+ lung cancer
Stephanie K. ALK+ lung cancer
Stephanie K. ALK+ lung cancer

This interview has been edited for clarity and length. This is not medical advice. Please consult with your healthcare provider to make informed treatment decisions.

The views and opinions expressed in this interview do not necessarily reflect those of The Patient Story.



I’m Stephanie

I’m from Massachusetts, and I was diagnosed with stage four ALK-positive non-small cell lung cancer in December of 2024.​

My life before cancer was a life full of hope and fun. I have two teenage daughters, and I’m married to my high school sweetheart, and we have been doing all kinds of great things. We go skiing. We travel. We both work full-time, while the girls are in high school and doing their thing. Right before diagnosis, I was very sick, and we thought I had pneumonia. So the right before diagnosis was a lot of coughing and a lot of inhalers and things like that. But the before life was one of more travel, adventure, activity, things like that.​

My early symptoms: coughing and feeling sluggish

As a mom, we put ourselves last. So when I was sick, I just thought it was a quick cold. I had just gotten over COVID, actually, and then I had a couple of great weeks, and then I started coughing again. So I thought it was just a little residual congestion from having COVID, and it just escalated, and the cough just wouldn’t go away. I didn’t really have other cold symptoms. I had just a terrible, hacking cough. It wouldn’t be resolved with any over-the-counter medication. Using cough drops didn’t help. I used an inhaler, like a steam inhaler, at night for some kind of relief, but nothing was doing the trick.​

So I did brush it off for a while and figured, “I’ll just deal with this later because I’m working full-time.” It was a busy time for me at work, and eventually I hit up the urgent care and figured that’s good enough. We’ll just get some kind of antibiotic and move along my way. After a few more weeks with antibiotics, nothing changed. It got worse. I went through more antibiotics and had a chest X-ray. The second time, they said it was pneumonia again, and we had new antibiotics. But again, I was still going to work every day, just going through the cycle of trying to pull yourself together and get everything you need to do done.​

It wasn’t until maybe eight weeks later, from my first visit to an urgent care, that I was coughing so hard that I actually broke a rib. I felt it snap as I coughed, and when that happened, the pain was actually what finally sent me to the hospital instead of an urgent care. The pain of that coughing was intense. I wasn’t going to the hospital with the concern of the cough. I was going because I needed pain medication that was stronger than ibuprofen.​

When I got there, they took a look at me and were like, “Did you have imaging done recently? Because we think it’s important that we do that again.” The ER doctor came in fairly quickly and decided he was going to admit me, which I thought was strange because, again, I still just thought I had a cold. I had pneumonia. I figured he was just admitting me because of the pain from the broken rib. It was actually a couple of days before I realized he was admitting me for more than pneumonia. I think they danced delicately around what they were testing me for at first, maybe to not scare me.​

On my second day in the hospital, when they told me I’d be getting a biopsy the next day, I was like, “Why would I need a biopsy for pneumonia? This is silly.” That was the reality for me of just how I pushed it aside for a long time. I mean, not very long — eight weeks maybe — that I was kind of just pushing it aside as a cold, and then it became real very suddenly for me.​

I was a young nonsmoker: how risk factors were missed

Absolutely, my age played a role, especially not having a history of smoking. That really was part of the lack, I think, of pushing quicker to get the diagnosis because I didn’t have your typical risk factors. I live in a pretty wooded area. I’m not in a city, so they weren’t thinking about air pollution. I don’t use a wood-burning or coal-burning stove in my house, so they weren’t thinking about it like that. I don’t smoke, and I was, again, 44 years old and fairly healthy. So we didn’t go there very quickly.​

What they saw in my lungs on the X-rays at urgent care looked like pneumonia to them. Without those other risk factors, they really didn’t say, “Well, it could be something else, so we should test just to make sure.” They said, “Hey, it’s the season. It’s September, October, November. People get sick. A lot of pneumonia is going around right now. You’re young, you’re healthy. It’s just that. Let’s treat it.”​

I wasn’t diagnosied until that hospitalization. But also very randomly in November, I had a couple of blood clots in my leg. Having the DVT in my leg finally made my PCP say, “Something doesn’t sound right here,” because that shouldn’t be happening. You don’t have any other reasons for that either. She referred me to a pulmonologist and a hematologist, whom I wouldn’t be able to see until February or March because they were booked so far out. Since I didn’t have your typical risk factors, they didn’t see it as urgent.​

For me, it was like, “Well, if you think something’s going on and there are some other puzzle pieces, I’m concerned.” I actually did start making calls to see if there was anybody I could meet with earlier. It was probably a two-week span between when she sent me a referral for hematology and when I actually went into the hospital and found out it was, in fact, lung cancer. I certainly wasn’t thinking lung cancer, though. I was more concerned with, like, why do you want me to see a hematologist? For whatever reason, I wanted to get there faster because, whatever you think this might be, I want to tackle it and get a solution in place quickly.​

I confronted lung cancer stigma as a nonsmoker

When you tell people you have lung cancer, the first question is, “Do you smoke?” I knew nothing of lung cancer before having it myself. I didn’t have any experience with anybody who’d had it before. I also believed in the stigma of, “It’s a smoker’s or old person’s cancer. It’s not something that you can just get out of the blue.”​

I’d never heard of a genomic test for any sort of cancer other than breast cancer and the BRCA gene. That’s the only time I’d ever heard of some kind of cancer test you could get to find out if you have the gene.​

When I was first diagnosed in the hospital, I had tumors on each of my ovaries, lesions in my spine, on my liver, and in my lungs. All I knew, though, was my ovaries, because I had a little sensitivity on my side. When they pushed on my stomach, I’d say, “Yeah, it hurts.” When they said I needed to do a biopsy, it was like, “Oh, it’s got to be something on my ovary.​“

They came back and said, “It’s cancer.” They just said, “It’s cancer.” I obviously was upset. But then my nurse was like, “Yeah, but if it’s ovarian cancer, that’s a quick and easy thing that we’ll just take out. You don’t want to have children anymore, so we can remove all of the parts that could be affected right now. I promise you, you’re going to be in great hands.” So I had this really different hope that it was just a tumor situation. We’d just remove it; we’re going to be fine.​

The following day, I was told that it was actually lung cancer and that they had biopsied my liver. The liver is what showed the lung cancer on the slides. Because I didn’t have the classic risk factors, the concern was that it was probably a genomic defect, a mutation. As we were starting to figure out what this was, the doctor mentioned that there could be these genetic tests that we needed to do, and we needed to button up whether it was just straight-up non-small cell lung cancer or if there was an actual mutation that we were up against, because you treat them differently. I also didn’t know that. In my head, you have cancer, you get chemo. That’s as far as I’d been aware of it.​

I was the first person in my family — my parents, my aunts, my uncles, my grandparents — to get cancer. It’s been a very healthy bloodline to date, and I was just shocked at what we’ve learned. I would say that what I learned about, “Every person with lungs can get lung cancer,” was only once I was one of those people, one of those lungs with lung cancer. That’s when I learned it really can be anyone with any risk factor. All you have to do is be breathing, basically, and you have that risk factor.​

Hearing “Stage 4” at 44, and redefining terminal vs. incurable

Hearing “stage 4” was terrifying. It was shocking. I think shock was probably the first thing, because I didn’t even know I was that sick. I knew I was sick with a cold. I knew I was sick with pneumonia. But to think you’re going to tell me I have cancer and it’s stage four already — how in the world did I not know? In my mind, you must have cancer for a really long time for it to get to be at stage 4. Unchecked cancer for a really long time, for it to grow.​

It was probably a matter of months, to be honest, because I was well in the summertime. To think about the fact that I started coughing in the fall and was diagnosed in early December — that was only a matter of months. It was a horrible shock at 44. When you’re not exposed to cancer with other people you know and your family members, you hear the word “stage 4,” and you immediately go to the word “terminal.” At 44, that’s a really scary thought because you just immediately think, “How long do I have? I am halfway through this existence that I thought I had. How are you telling me I’ve got a limited number of, I don’t know, months? Weeks? What are you even going to tell me?​“

The best thing that my doctors did was they never gave me a date. They never said, “You have an expiration date.” When we got to the point of understanding the mutation that I do have, because I’m ALK-positive, there are so many advancements and treatments that I can have, that people are living longer and longer at the stage four level. We’ve changed our language here at my house. We do not use the term “terminal” at all. We say “incurable cancer.”​

Even if I get to a point where there is no evidence of disease, I will always have this gene that’s just kind of waiting in the wings to come back out and scare me again. I recognize that I will be on medication for the rest of my life, making it more like a chronic illness. I need to keep that gene at bay. Keeping it under control, making sure it doesn’t come back and come up bigger by taking these medications, makes this something for me that I will never beat. It’s always in my system. I will never beat this cancer. That’s why it’s incurable, but not terminal. Because it’s not a timeline for me. It’s not a deadline. It’s not saying you only have so long to go. It’s just saying we’re going to work really hard to keep you as healthy as possible for as long as possible. It’s incurable, but we can manage this.​

Learning about ALK-positive lung cancer and targeted therapy

Because of the timing of when I was diagnosed and how fast it had already gone to so many areas of my body, the doctors felt it would be best to have one round of chemo while I was waiting for the genetic test to come back, because it’s not always guaranteed how fast it’s going to come back for each patient. It was just coming up to Christmas time, so there was also something about not being sure of where that test would end up on a lab bench somewhere, how fast it would get there. We scheduled my first round of chemotherapy for December 23rd last year.​

As I was sitting in that chair with my husband across from me, the phone rang, and I ignored it because it was some weird number from Pennsylvania. Then it rang again, and my husband was like, “That’s weird. Come on, why don’t you just pick it up? It’s probably not a telemarketer.” So he picked it up, and it was the doctor who originally diagnosed me at the hospital nearest my house, because we had gone to a cancer center at this point.​

The doctor called and said, “I wanted to be the one to tell you your genetic test came back. Have you started your chemo yet?” I was literally in the chair, and the nurse had the medicine right here, ready to go — are we doing this or not? He said, “It’s an ALK mutation, which, in this general area of conversation, is the best possible news I could give you, because there’s so much treatment out there and so much research, and you’re going to be okay in the sense of, you’re not going to need to stay with chemo, which can be very hard on your body. We’re going to be on targeted therapy.”​

He told me to go ahead and get that first round of chemo because they wanted to knock it down as much and as fast as they could. “Let’s do one round of chemo today, and then we’re going to see you back in the office in a week after you start to feel a little bit better post-chemo.” The way they explained it to me gave me a lot of hope, and it gave my husband a lot of hope to start to really dig in.​

The IV was in my arm. I’m getting the chemo. We’re both on our phones immediately Googling, “What in the world is ALK-positive cancer?” Not knowing anything about this, we were learning about cancer itself, the word “metastasized,” understanding what that even means, what stage 4 means, what ALK-positive means, and what the different types of treatments are. I was getting chemotherapy at that moment and wondering, “What’s the prognosis for the future?” Nobody was telling me, “You have this many years,” or “You have this many months.” Neither of us was ready to Google that. That’s a scary thing to ask, and neither of us wanted to get that answer because you just don’t know what you’re going to see.​

I found hope in the ALK-positive lung cancer community

We started to learn there was a great big community out there of ALK-positive patients, and they are so kind. They talk to each other about what’s going on. Sometimes the questions are, “I’m having a hard time with something — has anybody else experienced this?” But a lot of the time, it’s super positive. A lot of people are saying, “Hey, I just hit my anniversary. It’s been this many years since I’ve been diagnosed,” which was incredibly hopeful for me — to think that I could receive a stage 4 diagnosis, and here are people who are years into their stage 4 diagnosis.​

It helped us really reframe how we think about it, to think about it as the “incurable” phrasing, because we’re seeing so many other people who are successful in their treatment. Unfortunately, there are a lot of people who are not as successful, and that’s super hard to see. But the majority of what I’m seeing, at least through these communities that I’m a part of now, is just people wanting to help each other, people celebrating the lives that have been through it before, and the treatments that are on the horizon. 

There’s a lot of very promising activity in the space of ALK-positive lung cancer.​

Telling our teen daughters about lung cancer and the ALK mutation

The poor kids. I was in the hospital for a week, so they knew I was sick, but they also knew I had pneumonia. So they thought I was dealing with pneumonia this whole time. It was a Friday that I was discharged. They both had some activities that they had to go to on Saturday that were, believe it or not, fundraising events for childhood cancer at their school that they were helping to run.​

I certainly was not telling them before that. We just told them, “Mom’s better. She’s going to be okay. We’re out of the hospital. We have a plan. We’ll talk about this more later. Go have fun at your event, and we’ll talk.” We sat them down the next morning and said, “The reason I was out and what we found was that I do have cancer.” We did not tell them staging. We told them only that it was lung cancer. We didn’t tell them that it had spread anywhere. We told them just enough, I think, to make them feel included in the conversation but not to overwhelm them, because my husband and I didn’t have answers yet either.​

When we told them, it was before actually meeting with my now treatment team, my oncology team. We had met with the emergency room oncology team. We didn’t have a plan. We knew we were going to get chemotherapy in a couple of weeks. That was about all we knew. So we told them just enough to let them know, because they were 13 and 15 at the time. We said, “Mom has cancer. It is lung cancer.” They were as baffled as we were. We had to explain that there are different ways people can get lung cancer, and we’re going to learn all about it together, and we’re going to figure out what it means for us as a family.​

The next couple of weeks, it was a lot of cuddling, a lot of movie watching. I was sent home with an oxygen tank, so the poor kids had to see me with this thing strapped to me all the time. It was scary for them. Absolutely scary. My older daughter is very interested in becoming a nurse, so she was already tracking to be in the healthcare field prior to me being sick. She was in an anatomy and physiology class as well as a biology class that year. I didn’t want to overshare because I didn’t know quite how much she might actually understand and look up on her own, and panic, to be totally honest. So telling them just “lung cancer” without staging was very intentional.​

We let them get through the school year. We also let them get through a few rounds of me getting scans, and each time I got scans, it was better and better and better. We decided to wait until the school year ended in June. I had been six months into treatment at that point. We’d all celebrated a couple of rounds where I’d had a reduction in my tumor mass. We sat them each down individually to talk about what it really was, which was the hard part. This was telling them it had actually been in all these different areas and was considered stage four.​

We gave them the spiel about “incurable versus terminal.” We told my older daughter first, and she said, “I kind of knew.” She knew it was ALK-positive lung cancer and had started to do her own research, which I knew she would. She started to do a project in her anatomy class around ALK lung cancer, so she was learning a lot about it. What she learned is that one of the first things you see, and I didn’t realize this when we told them it was ALK, is that a majority of patients find out late stage that it’s ALK, because most of those patients don’t have risk factors. They are surprised by their diagnosis because of this mutation. So she sort of knew what was going on but kept it to herself for a while, and she was very strong about it throughout the year.​

When we told my younger daughter, she’s a very different person. She’s the artsy, English-major type versus the sciencey type. She said, “Okay, okay, I hear you, and I am just going to believe that it’s going to be okay because I’ve seen you over the last six months, and you went from having a gray face and being on oxygen and looking sick all the time to being who you are today, which is you seem like yourself again. You seem normal. You do what you normally do. We go on our little adventures again, and everything is going to be fine.” So she basically moved on. My older daughter was like, “Okay, I’m going to think more about this and do research, and I’m going to really understand it.”​

Since then, they’ve both become part of my little advocacy group because I have advocated for people to understand ALK-positive lung cancer better and to help with funding, because it’s a very unique cancer. We need to make sure that as patients, we’re part of the community that’s driving the research.​

So, about testing them. Luckily, this is one of those things where it’s a gene that in me just broke. It just broke on its own and decided to become cancerous. So it’s nothing that they can inherit, nothing that they have a risk factor for — other than being a person with lungs. Thankfully, that’s what we’ve been learning more about and understanding, that it’s very different from the BRCA gene with breast cancer. Anybody can, unfortunately, just have this kind of genomic mutation where it’s not hereditary, but it’s just something in your body that goes awry.​

Why I chose an ALK-positive lung cancer clinical trial

When I met with my oncology team the first time, it was overwhelming because there was so much I still didn’t really understand. I didn’t understand what my options were. I didn’t understand what ALK-positive was. I just didn’t know how to feel about it. To go in there and be presented with options, I thought, was really unique. I didn’t realize that would even be the way this conversation would go. I thought it would just be, “Let’s pick your chemotherapy regimen, and we’ll move along.”​

When they presented me with the different trial versus standard-of-care options, I think my personality is that I want to pay it forward. I’m a person who wants to be a part of what makes things better for more people, coming up with this. Receiving this diagnosis is not fun, but if I can be part of a medication that makes it better for people, because it has really great effects on the cancer but has fewer side effects than some of its predecessors, I want to be part of that movement. That was part of why I decided to be in the trial.​

The other part was very black and white. Part of it is that the drug that’s on market now does A, B, and C, but you’re going to have X, Y, and Z as side effects, and that’s not going to be fun. The clinical trial drug is the same drug that does A, B, and C, but it may have X, and that’s about it. You’re not quite sure; it may have none of those side effects. It felt to me like an obvious choice, almost like, why wouldn’t I take the drug that’s the same as the one on the market, but maybe has fewer problems?​

They told me it is just as good as what’s on the market right now. It is not a placebo. It’s not half as effective or anything like that. It is just as good as what’s on the market today, but hopefully better because you won’t have the side effects. So, between wanting to do the right thing to help others coming after me and, selfishly, not wanting the side effects, I thought, let’s go for it. It also came with a third thing: it was hopefully going to block the ability for this cancer to reach into my brain. ALK-positive cancer very frequently travels up into the brain.​

This new trial drug helps to block that, or that’s what they hope to find at the end of the trial — that it really does a good job of blocking that brain barrier. That’s what I fear every time I have scans: “Oh God, please tell me it didn’t go all the way up to my brain.” That being one of their selling points, in a sense, was worth being on the clinical trial.​

One of the benefits of being on a trial is that my care team felt a lot bigger. There were clinical trial nurses also keeping track of everything I was doing, as well as my standard oncology team. I had more frequent check-ins and scans because of it, and I felt really well cared for in my first year of treatment. Being on that trial meant that I had a dedicated person, on top of my care team, that I could talk to about the drug itself, to say, “Hey, this thing came up. Do you think that’s a side effect worth reporting, or is that just normal stuff?” For me, it felt like a no-brainer.​

Hip radiation, pain, and learning to advocate for my body

One of the lesions I have is at the top of my femur, called the femoral head. It’s right in the socket where you walk. That lesion was really bothering me a lot. It could never get rest because it was always being rubbed. I had been complaining of hip pain for a long time, not realizing it was because there was a lesion there. That was one of those things that was in my initial diagnosis, and I just never read that full-length report. I don’t think, at the time, I could have even digested it if I wanted to.​

Having hip pain that wasn’t really being helped by any medication, I started to ask more questions about what else could be done, because it was getting to the point where it was unbearable. The doctor mentioned that radiation might help. It might; it may not. It might not work, and it might work. Hopefully, it would zap that one lesion, and it would die or shrink, and maybe it would be easier as I walked.​

I found the radiation process to be less scary than I imagined. I think I was more scared going into it because I don’t understand radiation. Then it was super easy. I went for five days in a row. Luckily, the center is very close to my house, so it was about a 20-minute ride back and forth. I’d go, and I’d have the same care team every day, the same people to say hello to. They played nice music while I was in there. The lights were dimmed a little bit. It felt comfortable. They made it feel very casual, which was really helpful if you’re going somewhere every day to get this done.​

The first time was maybe 20 minutes or so, and it was the longest appointment. The rest were maybe 10 minutes after that. At the end, it was a wait-and-see to see if it worked or not, because it also causes inflammation which can itself cause more pain in that area. It was unclear for about eight weeks if it had actually worked or not. Right after having radiation, I had a spike in pain, which was not typical. I was walking with a cane and called the radiation oncologist to ask if this was normal. I knew there was going to be some pain, but this felt like more than “some pain.” This felt scary, like too much.​

Thankfully, she saw me right away, took an X-ray, and looked at everything. They wanted to make sure nothing was fractured, because radiation can also cause some bone brittleness. They confirmed nothing was fractured, so we were just doing the wait-and-see game again to see if maybe that was just more inflammation coming through. For me, I stopped using my leg as much because I was so nervous that maybe it was fractured, and that if I was on it a lot, I was going to suddenly break something, like osteoporosis. I was afraid it was going to just break out from under me.​

What I ended up doing was a disservice to myself, because all the muscles and ligaments around it got super tight. My physical therapist mentioned it was like leather: it gets harder, like leather, and it doesn’t move as freely. I caused myself to have less mobility because I was so afraid of hurting myself more. Now I’m at a point where I’m done with my cane. I don’t have the pain as frequently, but it didn’t resolve what I was hoping it was going to resolve when I initially went for radiation.​

It’s a very individual thing for every patient, how your body reacts and what it does for you. For me, it was trial and error, and I kind of wish I hadn’t done it. I don’t know if it’s the type of thing where I learned a bit about my body, too. After the fact, I asked for a physical therapy script so I could get moving again, get loose again, and that has helped me a lot. The biggest thing for me is learning how to advocate, because I advocated to do the radiation, but then I also advocated to get physical therapy to loosen myself back up.​

Losing independence: oxygen tanks, mobility issues, and asking for help

That loss of independence is tough. It’s really tough to understand that at 44, I was incredibly independent. I was the type of person who, if you went to the grocery store, I’d bring every grocery bag in one haul because I don’t want to go back out and do that. Or if I decide I’m going to move the furniture, I’m just going to do it myself. I don’t want anybody’s help. I was fiercely independent before this diagnosis.​

The way it sidelined me was dramatic. I was literally tethered to an oxygen tank for probably four weeks after my discharge. Talk about the opposite of independence. I was dependent on this machine following me around. I was dependent on anybody helping me carry the stupid thing if we went out and about somewhere, because it got heavy and was arduous to have with me. I wasn’t able to drive at the beginning because everybody around me was nervous that something was going to happen, and I wasn’t able to drive myself because of that.​

Every time I wanted to go anywhere, it was a huge project because somebody would have to drive me. They were kind to do it, but I didn’t like being dependent on somebody else. I want to be able to just go when I want to go. I had a lot of help. I had a lot of wonderful friends and my family who helped me with everything. If there was an appointment, there were a lot of appointments in the beginning.​

My oncologist said at the very beginning that this treatment, especially because it’s a clinical trial, is like a sprint. You’re just going from thing to thing to thing, and over two weeks, you’re going to be in appointments constantly. Then once that’s all done, you turn into marathon mode. You can get into a cadence, and your appointments will normalize. In the beginning, there were so many appointments. My husband also works full-time, so he was trying to juggle his job. I was out on leave from work, focused on my health.​

My parents were really kind. They drove me to appointments just to keep me company and to make sure I wasn’t struggling if I needed help with something. It was nice just to have company. It’s nice to be there with somebody who you can talk to or don’t have to talk to, but they’re there, so you feel that comfort.​

It was also hard because my daughters play club sports in the winter, and that’s my thing. I enjoy going to these club sports. It’s not a tax on me. I enjoy going. That would make us drive all over tarnation, going to tournaments. We’d be driving two hours away. I couldn’t do that anymore. It was disappointing to have to coordinate a ride for her or ask somebody if they’d be willing to come with us. My husband went to all of them because it’s his daughter, of course. But normally, I would just take off and go with her, and maybe he would meet us there halfway through. It was annoying to me to always have to ask for something, to ask for help. I’m not used to doing that.​

Over this past year, I’ve learned it’s okay to ask for help. Nobody’s upset about doing it. People actually want to help; they just don’t know how to. If you’re able to actually ask for the help, then people will happily give you a hand. If they don’t, then those aren’t the people that maybe you need in your close circle at that time. Right now, I just need the people who are going to matter the most when I’m going through the hardest thing I’ve ever gone through. That’s what my circle is to me. They’re the people I would call no matter what.​

How lung cancer changed my marriage

It’s weird to say, but I feel like this has been harder on my husband than on me. I think he internalized a lot of this pain, and I quickly tried to move into “What’s next?” mode. I don’t like to wallow in what’s happening. I’m just, what can I do next? How can I get better next? How can I get to the next thing? What’s the next landmark I can get to?​

In the very beginning, my husband was emotional. I think he just looked at me and was sad. When you think about your future with someone — we’ve been together since we were 15 years old — to be 44 and still together and in love, it’s hard to look at your future and imagine it not with that person. We haven’t known a life without each other. That’s really hard.​

It has probably made us closer, but we were already so close that it’s hard to say we’re closer now. There’s a difference in the kind of respect. I think he sees me as a fighter, and I see him as a fabulous caretaker. Once I started to feel better and feel like myself, we went back into our old roles, which was really nice, but with an extra layer of care. I don’t know that you really get that without having something like this in your family.​

You care for each other and your spouse when they’re sick with a cold, but there’s a whole other way of caring for someone when they’re sick with a chronic illness or with cancer. That deepened the love and care between us.​

Mom guilt, teen sports, and white ribbons

I’ve never put myself first, and that was a very big wake-up call for me — to put my health, my emotional health, and my mental health at the forefront. Those things all needed attention. I took nine months off work while I was battling my first year. During that time, once I started to feel better, I was prioritizing myself. It was the Stephanie Show. I was going to yoga twice a week. I was grabbing lattes with my friends. Whatever made me feel good and filled my bucket, that’s what I wanted to do.​

A lot of what I wanted to do was spend time with my girls. It was amazing to be home for the summer with them. I got to say things like, “Let’s just go run to the beach today because it’s a Tuesday and we can.”​

Part of my mom guilt was that I felt guilty in the beginning, which was silly because I couldn’t help it. I felt guilty that my daughter was on a new team. She didn’t really know anybody yet, and her mom was dragging around an oxygen tank to the games. Her mom was the one who maybe couldn’t be social with people, because I didn’t have it in me. I was exhausted, or I had masks on, which made me look very “don’t approach.” I did feel guilty for that.​

I felt like, “I hope I’m not alienating her with these new friends because they don’t really understand what we’re going through.” I wasn’t sure if she was telling them what we were going through. I might just look weird to other kids. I had that guilt until she showed me something that makes me emotional even now. She showed me that they had all tied white ribbons to their sneakers, the whole team. The white ribbon is for lung cancer. They all tied white ribbons to their shoes, not even knowing me and barely knowing her.​

That let go of that guilt because I realized she wasn’t embarrassed by it. She had told them, and they see me showing up still. So I’m okay. I’m going to be okay. She’s going to be okay, and we’re going to get through this. By the end of her club season, I was great. My tumor burden was down almost 55 percent within those first three or four months. I knew I was on track to become healthy and be myself again. I let go of a lot of that guilt because I recognized quickly that they’re going to be okay. The girls are good. They accept me for who I am, and they understand the diagnosis now. They can explain it to other people, and it doesn’t hold me back from being a good mom for them.​

One year after my stage 4 ALK-positive diagnosis: reflection and advocacy

It has helped me prioritize what’s important to me. I actually had my first anniversary this week, and I spent it at the spa because that’s what I wanted to do. Again, I’m prioritizing what makes me feel good and what makes me feel whole. I took a day to relax and reflect, and unplug from work so that I could really focus on myself and my family.​

At the one-year mark, I recognized that what’s important to me now is my family and myself, but also advocating. I need people to understand that people do not get cancer maliciously. When people look at you and say, “Oh, it must be because you did A, B, or C,” whatever people think a risk factor you’ve “caused” might be — nobody’s asking for cancer. We need to do a really good job of researching and continuing to advocate for those who are fighting it and for those who are living with the people who are fighting it, because those people need to be heard and seen as well.​

My work is in corporate philanthropy, and I have been in that field for about 20 years. Over time, I hadn’t really found my deep connection with one particular nonprofit that I get behind. Mostly because of the kind of work I do, I tend to support whatever I need to in the moment — something I’m running for work or something I’m affiliated with because of work.​

Now I am very clearly driven by my own diagnosis. This is something that I work on communicating about. I want people I know to understand ALK-positive cancer, and I want people to understand lung cancer in general, especially in younger people, more and more often. For me, it’s been an eye-opening experience to turn this into something positive. I have a real driven purpose and mission in life about ALK-positive cancer now.​

My kids have been great about trying to find ways to affiliate themselves with volunteering and getting involved in things. They support a lot of groups and clubs that have to do with cancer in general. What I’m really excited about is a future where I have more time because of the research being done and the drugs and treatments being manufactured now. They will give me more time with my family and more time to advocate on behalf of those who will eventually find out that they also have ALK-positive lung cancer.​

It’s important to me that people who are coming into this and who are young and just starting their families know that they have time with their families. It’s not as terrifying, perhaps, as what we all thought it was when we first got diagnosed. Rather quickly, you learn more about ALK and how you have hope.​


Stephanie K. ALK+ lung cancer
Thank you for sharing your story, Stephanie!

Inspired by Stephanie's story?

Share your story, too!


Learn about Lung Cancer Biomarkers

NSCLC Biomarkers Jill Feldman and Dr. Lovly Interview

What does “biomarker testing” actually mean in lung cancer? How can it change your treatment options? Jill Feldman and Dr. Christine Lovly explain it in plain language, including tissue vs. blood testing and questions to bring to your next appointment.


More ALK+ Lung Cancer Stories

Stephanie K. ALK+ lung cancer

Stephanie K., Non-Small Cell Lung Cancer, ALK+, Stage 4 (Metastatic)



Symptoms: Persistent and intense cough, general feeling of sluggishness

Treatments: Chemotherapy, targeted therapy through a clinical trial, radiation therapy
Ruchira A. ALK+ stage 4 lung cancer

Ruchira A., Non-Small Cell Lung Cancer, ALK+, Stage 4 (Metastatic)



Symptoms: Mild intermittent cough while talking, low-grade fever, severe nonstop cough, coughing up blood, collapsed left lung​

Treatments: Surgery (lobectomy), targeted therapy
Laura R. ALK+ lung cancer

Laura R., Non-Small Cell Lung Cancer, ALK+, Stage 4 (Metastatic)



Symptoms: Persistent cough, fatigue, bone pain

Treatments: Targeted therapies (tyrosine kinase inhibitors or TKIs, including through a clinical trial)
Shauna D. stage 4 ALK+ lung cancer

Shauna D., Non-Small Cell Lung Cancer, ALK+, Stage 4 (Metastatic)



Symptom: Persistent dry cough following a cold
Treatments: Targeted therapy (tyrosine kinase inhibitors), radiation therapy
Allison Z. stage 4 ALK+ lung cancer

Allison Z., Non-Small Cell Lung Cancer, ALK+, Stage 4 (Metastatic)



Symptom: Severe back pain
Treatments: Targeted therapy (ALK inhibitors), radiation therapy

Categories
ALK Chemotherapy Lung Cancer Metastatic Non-Small Cell Lung Cancer Patient Stories Radiation Therapy Targeted Therapy Treatments

Ruchira’s Stage 4 ALK+ Lung Cancer Experience, Biomarker Testing, and Breaking the Stigma

Ruchira’s Stage 4 ALK+ Lung Cancer Experience, Biomarker Testing, and Breaking the Stigma

When a mild, on-and-off cough first appeared in 2021, Ruchira never imagined it would lead to a diagnosis of stage 4 ALK-positive lung cancer. Healthy, active, and a lifelong nonsmoker, she was juggling work, travel, and time outdoors in Vancouver, British Columbia, when her dad urged her to get the cough checked. An X-ray, CT scan, and ultimately a PET scan and biopsy revealed adenocarcinoma in her left lung, shattering her assumption about lung cancer.

Interviewed by: Taylor Scheib
Edited by: Katrina Villareal

The road to that first diagnosis was long and emotionally draining. In Canada’s system, it took about eight months from the initial imaging to confirm lung cancer, as Ruchira cycled through scans, bronchoscopy, and biopsies, while hoping it might be something like tuberculosis instead. “It’s not only me, but also my family that’s along this ride,” she says, recalling how her father even suggested she return to India for faster care. Surgery offered early hope; margins were clear after a lobectomy, and everyone believed the cancer had been removed.​

Ruchira A. ALK+ stage 4 lung cancer

Within months, though, new symptoms surfaced. A low-grade fever, relentless coughing, and eventually coughing up blood led to more tests, the discovery of a collapsed left lung, and the news that her cancer had not only returned but had progressed to stage 4. Ruchira describes this second diagnosis as “mind-boggling,” coming before she had processed the first. She felt exhausted, scared, and deeply aware of how little control she had, even while self-advocating and staying on top of appointments.​

Biomarker testing changed the direction of her experience. Learning she was ALK positive opened the door to targeted therapy, and Ruchira began a once-daily pill that she calls a “miracle drug.” Within a week, her many symptoms eased, and within three months, she was told there was no evidence of disease.

Today, Ruchira frames her stage 4 ALK-positive lung cancer as a serious but treatable condition, one she manages while rebuilding her career, planning future travel, and investing in stress management and spirituality. She now speaks openly about biomarkers, stigma, and the importance of sharing stories so others feel less alone and know that advanced lung cancer is not always a death sentence.​​

Watch Ruchira’s interview or read the edited transcript below to find out more about her experience:

  • How listening to subtle symptoms, like a mild intermittent cough, can lead to earlier testing and answers, even when you feel otherwise healthy​
  • Why long diagnostic wait times can compound fear and uncertainty for both patients and families, making self-advocacy and persistence especially important​
  • How biomarker testing can dramatically change treatment options, opening doors to targeted therapies that may control stage 4 ALK-positive lung cancer with fewer side effects than chemotherapy
  • How a targeted therapy pill transformed Ruchira’s experience from escalating symptoms to no evidence of disease, allowing her to return to many of the activities she loved and to rethink what life with stage 4 cancer can look like
  • Every person’s cancer experience is unique, but no one should feel blamed or shamed​

  • Name: Ruchira A.​
  • Age at Diagnosis:
    • 53
  • Diagnosis:
    • Non-Small Cell Lung Cancer (NSCLC)
  • Staging:
    • Stage 4 (Metastatic)​
  • Mutation:
    • ALK
  • Symptoms:
    • Mild intermittent cough while talking
    • Low-grade fever
    • Severe nonstop cough
    • Coughing up blood
    • Collapsed left lung​​
  • Treatments:
    • Surgery: lobectomy
    • Targeted therapy
Ruchira A. ALK+ stage 4 lung cancer
Ruchira A. ALK+ stage 4 lung cancer
Ruchira A. ALK+ stage 4 lung cancer
Ruchira A. ALK+ stage 4 lung cancer
Ruchira A. ALK+ stage 4 lung cancer
Ruchira A. ALK+ stage 4 lung cancer
Ruchira A. ALK+ stage 4 lung cancer

This interview has been edited for clarity and length. This is not medical advice. Please consult with your healthcare provider to make informed treatment decisions.

The views and opinions expressed in this interview do not necessarily reflect those of The Patient Story.



Who I Am

My name is Ruchira. I was diagnosed with lung cancer. I’m a two-time survivor of ALK+ lung cancer. My first diagnosis was in May 2023, and my second diagnosis came the same year in October. I currently live in Vancouver, BC. I have been in North America for almost 26 to 27 years. I first lived in California and then moved to BC.

I enjoy many things. I enjoy the outdoors, nature, walking, hiking, and photography. I got into photography during the COVID pandemic. I started with food photography, then moved to landscape photography.

Traveling is about experiencing new cultures, new places, and new people. My parents were that way, and I think the love of traveling comes from them. I have traveled to quite a few places before cancer happened.

What My Symptoms Were

I was leading a normal life, a good life. I was working, traveling, and doing all of the regular things. In 2021, I started coughing a little bit when I would talk on the phone. My dad was the first person who noticed. He said maybe I should go to the doctor and have it checked.

I didn’t pay any attention to it because I was healthy. I had no health conditions. I didn’t feel any other symptoms either. The cough was very mild and intermittent. It wasn’t persistent. I thought maybe it was just a bug that I picked up and that it was going to resolve itself. A year went by and sometime in the middle of that year, the cough went away.

Another year went by and I got COVID, which is what made me go to the doctor. I told her that I had this cough and she promptly ordered an X-ray. The X-ray showed something, so the radiologist recommended that I get a CT scan done. She ordered a CT scan and they found a 3.5-centimeter mass on the lower lobe of my left lung.

After that, I was given a referral to a thoracic surgeon. I asked him if this mass was something to be concerned about. He asked me a bunch of questions and based on my responses, he thought that it was benign. I was living in the hope that maybe it wasn’t going to be anything. He ordered some pulmonary tests, a PET scan, a bronchoscopy, and a biopsy. My bronchoscopy and pulmonary tests were fine, but my PET scan and biopsy gave us the confirmation that it was adenocarcinoma and primary lung cancer.

The Shock of My Diagnosis

It was shocking. It was a long diagnostic process, but all throughout, I was hoping that it was a mistake. Maybe there was some confusion. I was traveling to India a lot, so maybe it could be tuberculosis or something else. I was hoping that. When you’re a nonsmoker, young, and healthy, you don’t think that it could be something as serious as lung cancer.

It was shocking. My first reaction was, “Oh my gosh, what do I need to do next? How do we move forward and handle this and solve this problem basically?”

The Agony of Wait Times

There is a big issue here. It took me six months to get my PET scan and another two months to get my bronchoscopy and biopsy. It was eight months in all. A lot of time went by because I was hoping that it would not be lung cancer. By the time the PET scan happened and we found out that there was this spiculated mass, we knew that it was moving in the direction of lung cancer.

It was difficult. It’s not only me, but also my family that’s along this ride. My dad even started to say that maybe I needed to go back to India and get the ball rolling there. It was very difficult.

I Didn’t Know Much About Lung Cancer

I had very little knowledge of lung cancer. We don’t have any family history of cancer. My knowledge was very limited. I had a lot to get up to speed on, not only about the disease but also about biomarker testing and available treatment options.

My original understanding was that lung cancer is one disease and it is treated by surgery and traditional treatments, like chemotherapy and radiation. As I went along the journey, I found that there is biomarker testing and the implications of that on treatment.

The Cancer Came Back

At that point, I didn’t even know about a recurrence. I had gotten my lobectomy done and was getting out of the hospital. My brother was with me and I was coughing again. He jokingly said, “This is why we went and got this surgery done in the first place, and here you are, coughing again.” I didn’t think it was anything because I was just getting out of the hospital.

When I had my follow-up with my surgeon, I told him about this. He responded that it’s something that some patients face after a lobectomy, that I should give it time and it would get better. I started focusing on my recovery and didn’t think anything of it.

In July, the symptoms, even the cough, settled down. August is when new symptoms began to emerge. I had a low-grade fever. The cough then became nonstop from morning to night. It was so bad that I couldn’t even talk to anybody. WhatsApp and emailing were my ways of communicating with people. There was also blood in my cough. I called my surgeon, of course, who began ordering tests again.

By October, I was back in the hospital. We did a bronchoscopy again and found out that I had a collapsed left lung and it would not stay inflated. We also found out that there was another tumor and the cancer was back. We did a PET scan and found out that it was stage 4.

Processing the Second Diagnosis So Soon After The First

It was so mind-boggling that it could come back so soon. You wonder what happened. I had just had the surgery. My margins were clear. The surgery was successful, so you wouldn’t think that it would come back so soon.

I hadn’t even begun to digest the shock of my first diagnosis, yet here I was dealing with a second one.

It was very scary to see blood. I was so mentally and physically exhausted by then, after having the surgery, nonstop coughing, and then seeing blood in it. It’s a lot to handle. The symptoms were the most difficult part of my journey.

I also felt that things weren’t in my control. You’re trying to do your best. You’re self-advocating. You’re on top of things as a patient. Yet the disease is progressing from stage 1 to stage 4. You think you’re curable. One minute, everything has gone fine and the cancer is out. The next minute, you find out that it’s incurable. It’s a lot to deal with mentally and emotionally.

Continued Waiting During the Second Diagnosis

The second time around still took about four to five weeks. As a patient, I was thinking that every day, something must be happening for this to be progressing that quickly, so every day matters. Four or five weeks is still a long time, so it probably contributed.

Discovering ALK-Positive and Biomarker Testing

After I got my first diagnosis, I started to read about the disease. I came across the ALK Positive group on Facebook. I was learning everything and reading everything that I could about this disease. Once I had my lobectomy and went for my follow-up, my surgeon had already ordered a FISH test, which is how I found out that I was ALK positive.

It was good that I found all this information from that Facebook group. I was reading people’s stories there as well. That is where I realized that two people can have lung cancer, but how their cancer behaves is dependent on biomarkers. I also learned how finding out about what gene mutation or fusion you have is so important because it has implications for finding the correct treatment for you.

Targeted Therapy: My “Miracle Drug” 

I am currently on targeted therapy, and it’s amazing. It has been a miracle drug for me. I had so many symptoms by the time my treatment started, but within a week of taking this drug, they all went away. In three months, I was declared to have no evidence of disease (NED).

It’s pretty easy. I take one pill a day, which feels like managing some type of chronic disease. There are fewer side effects than there would have been if I had chemotherapy. It has extended my life. It’s easy to manage. Yes, there are side effects, but there are fewer, so that’s good.

Redefining Stage 4 and Finding a New Normal

When I was going through my cancer year and all these events were happening, it was scary. I didn’t know what my life was going to be. In some ways, things have changed. But in many ways, I have been able to get back to the things in my life from before. That has been remarkable.

I feel so grateful and blessed that a targeted therapy drug exists for me. It’s amazing.

Cancer changes you. You have to go through the process and experience it. You want to get back to your old life, but in many ways, you’re not going to get it back. The changes are so subtle and so deep.

As I’m rebuilding my life after cancer, I’m focusing on stress management. I took some courses on stress management and spent more time on spirituality. I took some courses in breathwork, things that I had not done before. I started to do that. You listen to yourself a little bit more. You try to live fully. The things that used to hold you back before, you don’t allow them to hold you back anymore.

Becoming an Advocate and Sharing My Story

It has taken me some time. Once I found out that I was NED, I wanted to move on. I didn’t want to talk about cancer. I was so mentally and physically exhausted. I had a lot to process, which is what I did.

Around August 2025 or so, I felt like this was an experience that happened in my life and I needed to do something about it. I wasn’t on social media before, so I started an Instagram account and started sharing my experience, what worked for me, and what did not work for me.

Now I am thinking that the least I can do is share my story and educate others. I’m sure some people were like me, who carried a lot of stereotypes about lung cancer. Things like it’s a smoker’s disease or that it’s one disease and you do not know about these gene mutations that cause cancer. You think it is a lifestyle. You think, “Did I do something wrong? How did this come about?” It’s important to realize that there are many risk factors.

Breaking the Stigma Around Lung Cancer

There shouldn’t be any stigma to begin with. It’s not a moral failure. Lung cancer is a biological disease. It can happen to anyone. There are risk factors. Smoking is the number one risk factor, but there are other risk factors, too. Sometimes it could just be a random cell change that makes this cancer happen. For example, for me, ALK-positive is a gene rearrangement that caused this.

Sometimes you don’t have to do anything at all and this can still happen. There shouldn’t be stigma. People should feel comfortable getting themselves checked and getting help. They should not feel that they need to take any blame or shame for it.

Looking “Well” While Living with Stage 4

Strangers look at me and don’t realize that I’m a stage 4 cancer patient. I’m alone all the time.

I had that thought when I got diagnosed. “Is my life over?” But that’s not the truth. It’s not always a death sentence. With all these advances that are being made in treatment options, people are living longer lives. There is nothing to fear, I would say.

Now I’m starting to live my life. The past couple of years have been about adjusting to the side effects, managing them, and getting to grips with everything that has happened. Now I feel like I want to get out there. I want to do some work around this as well.

I’m focusing on building my career and moving forward. I’m looking forward to traveling again.

What I Want Others To Know

Even if you’re a nonsmoker and healthy, listen to your body. If there’s any little sign or change, go to the doctor and have yourself checked. Do not put it off, as I did.

You need to explore your treatment options and not fear lung cancer being a death sentence.

People should also go out and share their stories. I don’t know how many people do. I read somewhere that for lung cancer, people don’t share as much or it’s not mainstream. Recognizing the importance of why every story matters is key. It gives hope to patients and makes them feel less alone. It gives data to the medical community, to researchers, and it’s important for funding. People should share their story, like I am right now.


Ruchira A. ALK+ stage 4 lung cancer
Thank you for sharing your story, Ruchira!

Inspired by Ruchira's story?

Share your story, too!


Learn about Lung Cancer Biomarkers

NSCLC Biomarkers Jill Feldman and Dr. Lovly Interview

What does “biomarker testing” actually mean in lung cancer? How can it change your treatment options? Jill Feldman and Dr. Christine Lovly explain it in plain language, including tissue vs. blood testing and questions to bring to your next appointment.


More ALK+ Lung Cancer Stories

Stephanie K. ALK+ lung cancer

Stephanie K., Non-Small Cell Lung Cancer, ALK+, Stage 4 (Metastatic)



Symptoms: Persistent and intense cough, general feeling of sluggishness

Treatments: Chemotherapy, targeted therapy through a clinical trial, radiation therapy
Ruchira A. ALK+ stage 4 lung cancer

Ruchira A., Non-Small Cell Lung Cancer, ALK+, Stage 4 (Metastatic)



Symptoms: Mild intermittent cough while talking, low-grade fever, severe nonstop cough, coughing up blood, collapsed left lung​

Treatments: Surgery (lobectomy), targeted therapy
Laura R. ALK+ lung cancer

Laura R., Non-Small Cell Lung Cancer, ALK+, Stage 4 (Metastatic)



Symptoms: Persistent cough, fatigue, bone pain

Treatments: Targeted therapies (tyrosine kinase inhibitors or TKIs, including through a clinical trial)
Shauna D. stage 4 ALK+ lung cancer

Shauna D., Non-Small Cell Lung Cancer, ALK+, Stage 4 (Metastatic)



Symptom: Persistent dry cough following a cold
Treatments: Targeted therapy (tyrosine kinase inhibitors), radiation therapy
Allison Z. stage 4 ALK+ lung cancer

Allison Z., Non-Small Cell Lung Cancer, ALK+, Stage 4 (Metastatic)



Symptom: Severe back pain
Treatments: Targeted therapy (ALK inhibitors), radiation therapy

Categories
ALK Lung Cancer Metastatic Non-Small Cell Lung Cancer Patient Stories Treatments

Laura’s Stage 4 ALK+ Lung Cancer Experience Balances Treatment and Quality of Life

Laura’s Stage 4 ALK+ Lung Cancer Experience Balances Treatment and Quality of Life

For months, Laura managed a stubborn cough, but with a quiet pull from her intuition that something was not right. In South Carolina, where she ran a small handmade jewelry business, she also noticed deep fatigue and strange joint pain creeping into her days. These symptoms appeared slowly and at different times, so no clear connection was made. Intervention would come when, during a routine physical, she mentioned this year-long cough. A chest X-ray and CT scan were ordered right away and that’s when the truth emerged: a six-centimeter tumor and a diagnosis of stage 4 ALK-positive lung cancer.

Interviewed by: Carly Knowlton
Edited by: Chris Sanchez

Laura’s treatment for ALK-positive lung cancer initially focused on targeted therapies called tyrosine kinase inhibitors or TKIs. Laura cycled through several options, always balancing side effects against her quality of life. “If this is what my life is going to be like… it isn’t worth it,” she recalls, after struggling with the severe side effects of her first TKI. (Editor’s Note: TKIs work by blocking tyrosine kinases, enzymes that may be too active or may be found at high levels in some types of cancer cells. Blocking tyrosine kinases may help keep cancer cells from growing.)

Laura R. ALK+ lung cancer

Encouraged by her physician to prioritize what mattered to her, Laura took breaks, joined a clinical trial, and ultimately found a better fit with her current medication. “Patients should advocate for what works best; if side effects or treatments aren’t acceptable, speak with your doctor about changing things,” she says.

Laura’s ALK-positive lung cancer experience fundamentally shifted her identity and outlook. She speaks candidly about the grief and recalibration forced by advanced cancer, the evolving sense of self, and the acceptance of cancer as a chronic condition, if a life-defining one. Daily life is different, but Laura leans on support groups and prioritizes humor and connection.

“Given any type of tragedy, you either decide to learn from it, rebuild from it, or let it take you down,” Laura says. “And I think more of us decide not to let it take us down.” 

Watch Laura’s video above, and scroll down to read through her edited interview transcript for more on:

  • Why you should advocate for thorough diagnostics if your symptoms persist, regardless of smoking history or age
  • How quality of life is essential; it’s valid to adjust or pause treatment if side effects outweigh benefits
  • How proactive support in the form of family, community, mental health, and provider relationships can transform even the hardest experiences
  • Why humor, connection, and redefining identity are key to sustaining hope and finding meaning
  • How Laura has learned to accept new limitations, embrace choice, and support others through lung cancer community groups

  • Name: Laura R.
  • Age at Diagnosis:
    • 37
  • Diagnosis:
    • Non-Small Cell Lung Cancer (NSCLC)
  • Staging:
    • Stage 4
  • Mutation:
    • ALK
  • Symptoms:
    • Persistent cough
    • Fatigue
    • Bone pain
  • Treatments:
    • Targeted therapies: tyrosine kinase inhibitors (TKIs), including through a clinical trial
Laura R. ALK+ lung cancer
Laura R. ALK+ lung cancer
Laura R. ALK+ lung cancer
Laura R. ALK+ lung cancer
Laura R. ALK+ lung cancer
Laura R. ALK+ lung cancer
Laura R. ALK+ lung cancer
Laura R. ALK+ lung cancer
Laura R. ALK+ lung cancer

This interview has been edited for clarity and length. This is not medical advice. Please consult with your healthcare provider to make informed treatment decisions.

The views and opinions expressed in this interview do not necessarily reflect those of The Patient Story.



My name is Laura

I live in South Carolina. I was diagnosed in May of 2023 with stage 4 non-small cell ALK-positive lung cancer.

It’s changed a little bit since my diagnosis, but before that, I owned a small handmade jewelry business. I still own it, but I do that part-time now. What I do for fun is horseback riding. I don’t get to do it as much as I’d like, but hopefully more so in the future now.

I try really hard to be funny. Whether or not I am, I don’t know, but I think I’m funny.

My first symptoms and red flags

It was hard because I overworked myself. I was very focused on work. I should have gone in sooner. 

The first sign was a cough that wouldn’t go away. I’d been coughing for almost a full year, but it wasn’t bad. It was just a little bit in the morning. Sometimes during the day, I wouldn’t cough at all. It was just in the morning. Sometimes the cough would produce phlegm, sometimes it wouldn’t. Some days it got better, other days it got worse. It was a persistent cough that didn’t go away. 

Over the years before my diagnosis, I became more fatigued, but gradually. I was approaching my late 30s, and I wondered, “Am I just getting old? Why am I tired all the time?” I also had a lot of joint issues, not debilitating, but pains in my wrist. I complained to my doctor, and she prescribed arthritis cream. I was in my 30s and wondered if that was normal. She said, “Yeah, it happens to some people.” 

Those were the main symptoms: joint pain, fatigue, but the biggest one was the cough. I was lucky to have a cough because where the tumor was located, it was close to a bronchial opening, so the tumor caused almost an obstruction. I was trying to cough it out, but you can’t cough out a tumor.

I didn’t go to the doctor immediately. I lived with it, hoping it would go away. I was self-medicating. I’d always had allergies, so I kept taking allergy medications, switching between Allegra and others, but nothing helped. 

At my yearly checkup, I talked about arthritis and back pain. I brought up the cough, and the doctor was concerned. She asked if I was from a region where there are common fungal infections in the lungs. I wasn’t. She thought a cough that long was unusual, so she sent me for a chest X-ray at the VA. The X-ray found a tiny nodule a few millimeters across. They said it’s common with service members and ordered a CT scan to monitor the size. After the CT scan, instead of a six-millimeter nodule, it turned into a six-centimeter mass, which is very large. That started the diagnosis process in May 2023.

Finding my care team

My first care team was a whirlwind, but I have healthcare through the VA, so it was all covered. 

They told me to see a pulmonologist. I was referred to Dr. Nicole Tanner at MUSC in Charleston. She is amazing. She made me feel comfortable. She showed me the CT scan and explained the next steps with biopsy and diagnosis. 

The VA is attached to MUSC, so I’ve received excellent care, and everything moved quickly. Waiting two days for a phone call felt long at the time, but the diagnosis from primary care to biopsy was within two weeks. I was given a pulmonologist and an oncologist. 

At the VA, you can get a second opinion, so I got recommendations for a local thoracic oncologist. I also researched and found a specific ALK-positive specialist.

My reaction to my diagnosis

The news was given to me over the phone, which was fine. After the CT scan, my primary care doctor called quickly and said, “We’re going to do this.” I asked, “Why do I need to see an oncologist? Could this tumor be something else?” She said, “No, unfortunately, it’s cancer.” 

It took me by surprise. I Googled possibilities, but didn’t think it was cancer. I said, “There’s absolutely no way.” 

It took me a long time to believe it. I don’t even know when I fully recognized I had lung cancer.

I am a nonsmoker. We all went through COVID and had coping mechanisms, but that was rare and not a daily thing. Cigarette smoke? No.

Being diagnosed and treated for cancer as a woman in your late 30s is intense emotionally, hormonally, and mentally, because you’re aging and things are changing. 

You think about childbirth, not being young anymore, friends with kids… it’s difficult to cope with all at once. I had to slow down after the diagnosis. It’s way too much for anybody to take on by themselves.

You have cancer, you can’t do this or that, you have to take medication, and then side effects prevent you from doing things. It’s too much.

Genetic testing impacted my treatment options

We waited to get my PET scan results to stage me. 

Since I wasn’t presenting as poorly as some, maybe because of my age, there was no need to start chemo until genetic results came back. The genetic results [ALK positive] gave good news; there was a targeted therapy for me. 

I started first-line therapy with my first TKI two years ago. Now I’m on my third.

Surgery isn’t an option, since my cancer is stage 4 metastatic; it has spread to different areas. Some elect to have surgery, but for me, surgery isn’t curative, so it’s not an option.

My experience with TKIs, their impact, and side effects

The first TKI wore me down. I lasted about a year, but couldn’t handle the side effects physically or mentally. I felt worse than before I had cancer, and I almost gave up. My specialist said that no one would force me to take it, which was freeing. I took a break, but the cancer grew back. 

Then Dr. Lynn at Mass General told me about a clinical trial with cutting-edge medication. It’s rigorously tested and the latest available. I got on the trial, but my liver couldn’t tolerate the medication, which is common. I had some side effects from the clinical trial drug, but it was much better than the first drug. I loved the medication and was sad to stop.

I stopped and started my third TKI a month ago, and I’m doing pretty well so far. Hopefully, this one will stick. The drug I’m on now has minimal side effects. I increased my dose after consulting with my doctor because I had no side effects and wanted to see if the higher dose would hold.

There’s no end to it; treatment keeps going. TKIs are not a cure but must be taken until they stop working. Monitoring is constant with CT scans every three months to check tumor size. If it stays the same, that’s good news. Residual cells never go away. Researchers are working on vaccines and cures, but it’s a long process.

I kept my care at Duke University Hospital, where the clinical trial was run and supervised by an ALK-positive specialist. Instead of returning to Charleston, I now see the ALK specialist at Duke.

My current work and support system

I’m doing jewelry part-time and have stepped back a lot. Having my own business is great because I can return when I want. The connections are still there, just fewer. I pick when to work.

I have a lot of friends. My recently made friend, Emily, now lives in Washington state and has helped a lot. My sister, my only family member, left before, and our relationship wasn’t good. The diagnosis didn’t improve things, but we worked hard to rebuild our relationship, and it’s gotten much better. That’s one good thing about cancer; it brought my sister and me closer.

The impact of cancer on my daily life

The first year was the hardest; the second year was also difficult, mostly in finding a new normal. It’s like grieving loss, scrambling to survive, and rebuilding. It’s completely overwhelming, but you either do it or you don’t.

I have to do it. With any tragedy, you either learn and rebuild, or let it take you down. Most decide not to be taken down.

The hardest moment I’ve faced so far was deciding to stop the first TKI. I was going through a lot, dealing with side effects, life changes, and reflecting on a year of medication with a worse quality of life. I’d basically given up and stopped medication. 

When I spoke to Dr. Lynn, she said, “What are you doing? You don’t have to take it.” I didn’t know that.

I’m fortunate to have supportive friends willing to help whenever I need it. Mental health is very important for people with this diagnosis since it’s life-changing. Some people aren’t sure what to do. There are many who care and want you to fight.

My identity has completely changed because I will always carry cancer; there is no cure. I think about death every day, almost like a built-in ticking time bomb. Not that I expect to die tomorrow, but it’s always there. At the same time, I appreciate life and can do what I want, such as take medication or not.

Therapy experience and my quality of life

I was already in therapy before the diagnosis and continued afterward. 

I learned to speak up and eventually switched therapists, which was the best decision. If you don’t like your therapist or aren’t getting better, get another one.

Quality of life is often overlooked in cancer care, but it’s crucial that patients aren’t tortured to death. For me, quality is more important than length of life. 

Everyone’s priorities are different. Some want to live at any cost. I think this changes how care should be delivered. 

If you don’t like your treatment, talk to your oncologist. There are usually other options. 

Advocacy is vital because your life won’t get better until you ask for change.

My advice for others

You’re not alone. 

One of the best things I did was find a support group online. A friend recommended it, and connecting with others who understand made a big difference. 

We all go through similar things, though differently. Having that support group has helped a lot over the past two years.


Laura R. ALK+ lung cancer
Thank you for sharing your story, Laura!

Inspired by Laura's story?

Share your story, too!


More ALK+ Lung Cancer Stories

Stephanie K. ALK+ lung cancer

Stephanie K., Non-Small Cell Lung Cancer, ALK+, Stage 4 (Metastatic)



Symptoms: Persistent and intense cough, general feeling of sluggishness

Treatments: Chemotherapy, targeted therapy through a clinical trial, radiation therapy
Ruchira A. ALK+ stage 4 lung cancer

Ruchira A., Non-Small Cell Lung Cancer, ALK+, Stage 4 (Metastatic)



Symptoms: Mild intermittent cough while talking, low-grade fever, severe nonstop cough, coughing up blood, collapsed left lung​

Treatments: Surgery (lobectomy), targeted therapy
Laura R. ALK+ lung cancer

Laura R., Non-Small Cell Lung Cancer, ALK+, Stage 4 (Metastatic)



Symptoms: Persistent cough, fatigue, bone pain

Treatments: Targeted therapies (tyrosine kinase inhibitors or TKIs, including through a clinical trial)
Shauna D. stage 4 ALK+ lung cancer

Shauna D., Non-Small Cell Lung Cancer, ALK+, Stage 4 (Metastatic)



Symptom: Persistent dry cough following a cold
Treatments: Targeted therapy (tyrosine kinase inhibitors), radiation therapy
Allison Z. stage 4 ALK+ lung cancer

Allison Z., Non-Small Cell Lung Cancer, ALK+, Stage 4 (Metastatic)



Symptom: Severe back pain
Treatments: Targeted therapy (ALK inhibitors), radiation therapy

Categories
ALK Lung Cancer Non-Small Cell Lung Cancer Patient Stories Radiation Therapy Targeted Therapy Treatments Tyrosine kinase inhibitor (TKI)

Shauna’s Story of a Cold, a Cough, an X-ray, and Stage 4 ALK+ Lung Cancer

Everything was Fine Until It Wasn’t: Shauna’s Story of a Cold, a Cough, an X-ray and Stage 4 ALK+ Lung Cancer

Shauna was living her healthiest, most active life at 51 when everything shifted. After what seemed like a simple cold in the fall of 2018, she noticed a cough that wouldn’t go away. A quick trip to urgent care during her lunch break led to an unexpected X-ray, and within days, she learned there was a mass in her lung. Not long after, a biopsy confirmed the diagnosis: stage 4 ALK-positive lung cancer.

Interviewed by: Nikki Murphy
Edited by: Katrina Villareal

Naturally, the news was shocking. Shauna had no family history, had never smoked, and had just sent her kids off to start their own lives. She and her husband were busy, working full-time, and looking forward to the next chapter. Instead, she had to face something that seemed impossible.

Shauna D. stage 4 ALK+ lung cancer

From the start, Shauna leaned into both her medical team and the online ALK-positive lung cancer community. She discovered support groups on Facebook, where people openly shared knowledge and resources. That encouragement helped her seek second opinions from specialists in Nashville and Boston, giving her confidence in her care. Although she stayed with her local oncologist for several years for convenience, she eventually transitioned to a larger hospital in Indianapolis to explore clinical trials and gain access to more advanced care.

Shauna’s treatment has centered on targeted therapies. Her first tyrosine kinase inhibitor (TKI) kept her stable for about five years, even though she had to adjust her dosage due to side effects like bradycardia and pneumonitis. She also underwent radiation for specific spots of growth along the way. (Editor’s Note: A tyrosine kinase inhibitor is a type of targeted therapy used to treat cancer. Tyrosine kinases are enzymes that may be too active or found at high levels in some types of cancer cells, and blocking them may help keep cancer cells from growing.)

By 2024, when new nodules appeared, she switched to a second TKI. Thankfully, her scans are stable again, and she feels better on this newer medication, with fewer side effects and more energy.

Through it all, Shauna has prioritized mindset and lifestyle. She focuses on staying as healthy as possible, embracing a mostly vegan diet, exercising, and paying attention to how her body responds. Though stage 4 ALK-positive lung cancer is treatable but not curable, she chooses not to live in fear. Instead, she invests in her relationships, grateful for every moment she’s been able to spend with them.

She’s also thinking ahead about clinical trials, recognizing how important they are for advancing treatment and offering patients more time. Her biggest challenge is knowing her time may be cut short, but she finds peace in her faith and purpose in encouraging others. As she puts it, life is short for all of us. She reminds people to live fully, not to waste days in worry, and to be kind.

Shauna’s story highlights the importance of support, second opinions, staying proactive, and holding onto hope while navigating life with stage 4 ALK-positive lung cancer.

Watch Shauna’s interview to find out more about her story:

  • How a lingering cough led to a life-changing diagnosis
  • Why she turned to online communities for knowledge and support
  • The role her husband and family play in her care and outlook
  • What clinical trials could mean for her and others with ALK-positive lung cancer
  • Her message about choosing hope and living fully each day

Scroll down to read the transcript of Shauna’s interview.


  • Name: Shauna D.
  • Age of Diagnosis:
    • 51
  • Diagnosis:
    • Non-Small Cell Lung Cancer (NSCLC)
  • Staging:
    • Stage 4
  • Mutation:
    • ALK
  • Symptom:
    • Persistent dry cough following a cold
  • Treatments:
    • Targeted therapy: tyrosine kinase inhibitors (TKI)
    • Radiation therapy
Shauna D. stage 4 ALK+ lung cancer
Shauna D. stage 4 ALK+ lung cancer
Shauna D. stage 4 ALK+ lung cancer
Shauna D. stage 4 ALK+ lung cancer
Shauna D. stage 4 ALK+ lung cancer
Shauna D. stage 4 ALK+ lung cancer
Shauna D. stage 4 ALK+ lung cancer

This interview has been edited for clarity and length. This is not medical advice. Please consult with your healthcare provider to make informed treatment decisions.

The views and opinions expressed in this interview do not necessarily reflect those of The Patient Story.



Hi, I’m Shauna

My name is Shauna. I live in Indiana. I was diagnosed with stage 4 lung cancer in 2018.

My family and friends would describe me as dependable and fun-loving.

When I first noticed something was wrong

Early in the fall of 2018, I had an illness, a normal cold, but my cough stayed after a couple of months. It didn’t go away. During lunch break at work, I went to an urgent care clinic where they did an X-ray and found a mass in my right lung. The person who did my X-ray talked to me about seeing the mass and told me I would need to see a pulmonologist and get scheduled.

As you can imagine, I was shocked. I scheduled with a pulmonologist and he scheduled a biopsy. I had a needle biopsy and all the scans that came after, and the biopsy came back positive for cancer.

The moment everything changed

I had just turned 51 that October and I was diagnosed in November. I was in the best shape of my life. My two kids had just flown the nest, and my husband and I were still working full-time. I was shocked. I had been eating well and exercising. I don’t have a family history of lung cancer. I have never smoked. It came out of nowhere. It was upsetting, for sure.

I searched for a different opinion

I live in a more rural area in Indiana, so we’re not close to any big hospitals. I started with a pulmonologist who was local and very good, and he was able to do what I needed done and diagnosed me. Then I found an oncologist who was local as well.

I came across a Facebook group for ALK-positive lung cancer, which helped a lot. It’s very educational, informative, and supportive. The people in that group have a lot of knowledge and that steered me to think of getting a second opinion, so I did. I went to a specialist in Nashville, Tennessee, and at Mass General in Boston, who is an ALK-positive lung cancer specialist.

I stayed with my general oncologist for about five years because I knew I was getting the standard of care. The treatment would be the same as I would get anywhere, and it was convenient being close to home. But since then, I have switched my care to a bigger hospital in Indianapolis because things are getting a little more complicated and I know I’ll have better access to clinical trials. It’s just a better facility.

It was pretty easy for them to tell, even with just the X-ray. They could see that it was in both lungs. I have innumerable little nodules in both lungs and one primary tumor in my right lung, so that made it stage 4.

How I learned about my biomarker

One of my second opinion doctors, who I see now at the Indianapolis hospital, is the one who submitted my sample to a company for biomarker testing. Everyone on my team knew what direction to go. I didn’t have that problem at all. Right off the bat, I’d say within a few weeks, I came back as ALK positive. I knew that there was a mutation and the thoracic oncologist told me that I likely had a mutation because of my age and some other things.

My treatment plan

Immediately, they started me on my first tyrosine kinase inhibitor (TKI) and at the full dose. I had some of the more serious side effects right away, like bradycardia and pneumonitis. My oncologist would lower the dose each time I experience an event like that.

At the time, that was the best and newest TKI available. We decided to stay the course and see because it had been proven with others that you could take half the dose and have it still be effective. In my case, that’s what we found. I was able to take half the dose and all the side effects went away. I was stable. I was never no evidence of disease. It probably shrank my original tumor about 40% and I’ve been stable since that time.

I was also able to scale my dose back up. By the last couple of years on that TKI, I was taking the full dose again with none of the same serious problems. I was on that first TKI for about five years until I started having some new spots in my left lung.

Then I had radiation. I don’t know what year that was exactly. They were about a year apart from each other. The radiation was targeting a certain spot where they thought they saw growth. Then I was stable and continued to stay on my first TKI.

In mid-2024, we started noticing some more growth in different spots. We were beginning to realize we had probably run out of time on my first TKI and that maybe it was time to switch because there was a newer drug out by that time. Research is so important because if I didn’t make that jump, that would have been it.

I started on my second TKI in August 2024 and that’s what I’m on right now. I have had some questionable scans, but my last scan in Indianapolis read stable.

What life is like on a targeted therapy

I haven’t had a lot of problems with side effects on either drug. I know I had a couple of serious ones off the bat because I was probably taking too big a dose for my body to adjust to it, but then I was able to go back to the full dose.

With the first TKI, I had a lot of bloating, awful constipation, and some sensitivity, but the side effects are nothing compared to the drug working. To me, that’s the most important thing.

When I was out in the sun, I learned to wear sunscreen, a rash guard, and a hat. I got used to how long I could stay out in the sun without burning. I found something to use for the constipation.

The second TKI causes a little neuropathy and tingling in the hands. I live with it, but that went away somewhat. I don’t even notice it now. I have so much more energy on this TKI as well and not as much weight gain. I’m very happy with this, as long as it’s working.

I thought that I would throw everything at it and make sure my body was in optimal position to fight what may come. As we know, it’s terminal, so I’m trying to live as long as I can. I’ve always been pretty healthy. I always exercised and took care of myself, but I’ve taken it to a whole new level now. I’m mostly vegan and eat anything that’s anti-cancer and strengthens my immunity.

I’m considering clinical trials

I came back from a conference in San Diego, where they talked a lot about clinical trials. The ALK+ Summit was there. They have a yearly conference that’s so informative because they have amazing doctors and patients who talk.

Clinical trials are the only way these new drugs will ever come into play. They have to go through trials to be approved so that everyone can benefit. I’ve spoken to my oncologist and though it’s not something we’re necessarily looking for yet, it’s definitely on my mind.

What my biggest challenge has been

My future as a grandma is gone. I have seven grandchildren and I was able to see a lot of them be born since my diagnosis. I feel for the younger moms with kids at home. I’m thankful that I was able to raise my kids.

Cancer is so prevalent everywhere you look now, in younger and younger people, and all kinds of cancers. I can’t say I was necessarily that surprised. I was surprised at what type of cancer I ended up with, but it happens everywhere.

I would love to be on treatment indefinitely if it would last that long and if this could be treated like a chronic illness.

My message of hope

I have my faith. My hope is in my eternity. I realize that life is short. It’s short for all of us. It’s but a vapor. My life here on earth may be cut short, but I live each day to the fullest and try to be kind to everyone. I’m enjoying my family and friends, and I try to have a balance in life with this diagnosis.

I have my main people: my two daughters, my sister, my husband, and my parents. Those are the people whom I feel like I could go to right at the beginning and anytime I’ve needed them.

What I want others to know

Life is short. Take each day as a new chance. Don’t be scared. Don’t live your life in fear. It took me about two years before I was able to not worry anymore. I’m not going to worry about this one more day. I’m going to live like I have all the time in the world.


Shauna D. stage 4 ALK+ lung cancer
Thank you for sharing your story, Shauna!

Inspired by Shauna's story?

Share your story, too!


More ALK+ Lung Cancer Stories

Stephanie K. ALK+ lung cancer

Stephanie K., Non-Small Cell Lung Cancer, ALK+, Stage 4 (Metastatic)



Symptoms: Persistent and intense cough, general feeling of sluggishness

Treatments: Chemotherapy, targeted therapy through a clinical trial, radiation therapy
Ruchira A. ALK+ stage 4 lung cancer

Ruchira A., Non-Small Cell Lung Cancer, ALK+, Stage 4 (Metastatic)



Symptoms: Mild intermittent cough while talking, low-grade fever, severe nonstop cough, coughing up blood, collapsed left lung​

Treatments: Surgery (lobectomy), targeted therapy
Laura R. ALK+ lung cancer

Laura R., Non-Small Cell Lung Cancer, ALK+, Stage 4 (Metastatic)



Symptoms: Persistent cough, fatigue, bone pain

Treatments: Targeted therapies (tyrosine kinase inhibitors or TKIs, including through a clinical trial)
Shauna D. stage 4 ALK+ lung cancer

Shauna D., Non-Small Cell Lung Cancer, ALK+, Stage 4 (Metastatic)



Symptom: Persistent dry cough following a cold
Treatments: Targeted therapy (tyrosine kinase inhibitors), radiation therapy
Allison Z. stage 4 ALK+ lung cancer

Allison Z., Non-Small Cell Lung Cancer, ALK+, Stage 4 (Metastatic)



Symptom: Severe back pain
Treatments: Targeted therapy (ALK inhibitors), radiation therapy

Categories
ALK ALK inhibitor Lung Cancer Non-Small Cell Lung Cancer Patient Stories Radiation Therapy Targeted Therapy Treatments

Allison’s Example of Self-Advocacy Living with Stage 4 ALK+ Lung Cancer

Allison’s Example of Self-Advocacy Living with Stage 4 ALK+ Lung Cancer

Allison describes herself as outgoing, energetic, and always on the move, so when back pain began interrupting her workouts and daily activities in late 2022, cancer wasn’t even on her radar, let along stage 4 lung cancer (ALK positive). She pushed through months of pain, assuming it was a muscular issue, until one night in May 2023, when her husband had to carry her to the bathroom. That moment shifted everything.

My Stage 4 Lung Cancer Diagnosis Video

Interviewed by: Nikki Murphy
Edited by: Katrina Villareal

After urgent care scans revealed spinal lesions, Allison’s medical background helped her piece together what was happening before doctors even confirmed it. Within weeks, she learned she had stage 4 ALK+ lung cancer, a diagnosis that felt surreal for someone who never smoked, lived a healthy lifestyle, and was deeply engaged in her family and community. The shock was intense, but Allison quickly realized that information, self-advocacy, and support would be key to moving forward.

Allison Z. stage 4 ALK+ lung cancer

Once biomarker testing identified her ALK mutation, she started an oral targeted therapy. The results were dramatic. Within a week, Allison’s pain diminished, and she was able to sleep comfortably again. However, treatment wasn’t without hurdles. She dealt with side effects like a severe rash, high cholesterol, neuropathy, and swelling, but she leaned on her medical team, expert consultations, and peer support groups to find ways to manage. Alongside medication, she underwent radiation to stabilize her femur and strengthen her bones against further damage.

Throughout her experience, Allison has emphasized the importance of self-advocacy. She highlights the importance of asking questions, seeking second opinions, and bringing ideas to doctors, especially since rare mutations like ALK require specialized expertise. She continues to work closely with her local care team and renowned experts to explore treatment strategies, including potential clinical trials and even surgical removal of her primary tumor.

Living with stage 4 ALK-positive lung cancer has changed Allison’s perspective. She now plans life in 90-day increments between scans, while still looking ahead to milestones with her kids and future adventures. Although the unknowns remain challenging, Allison focuses on hope, community, and joy. She encourages others to face the light, believe in progress, and remember that anyone with lungs can get lung cancer. Her message is one of resilience, empowerment, and choosing to live fully while navigating life with cancer.

Watch Allison’s video to find out more about her story:

  • How back pain turned out to be a sign of stage 4 ALK-positive lung cancer
  • Why never smoking didn’t protect Allison from a lung cancer diagnosis
  • The targeted therapy that brought her relief within just one week
  • How self-advocacy shaped her care and treatment decisions
  • The hope and positivity that guide her every step forward

Biomarkers and Targeted Therapy: How Lung Cancer is Treated Today


  • Name: Allison Z.
  • Age of Diagnosis:
    • 45
  • Diagnosis:
    • Non-Small Cell Lung Cancer (NSCLC)
  • Staging:
    • Stage 4
  • Mutation:
    • ALK
  • Symptom:
    • Severe back pain
  • Treatments:
    • Targeted therapy: ALK inhibitors
    • Radiation therapy
Allison Z. stage 4 ALK+ lung cancer
Allison Z. stage 4 ALK+ lung cancer
Allison Z. stage 4 ALK+ lung cancer
Allison Z. stage 4 ALK+ lung cancer
Allison Z. stage 4 ALK+ lung cancer
Allison Z. stage 4 ALK+ lung cancer
Allison Z. stage 4 ALK+ lung cancer

This interview has been edited for clarity and length. This is not medical advice. Please consult with your healthcare provider to make informed treatment decisions.

The views and opinions expressed in this interview do not necessarily reflect those of The Patient Story.


Allison Z. stage 4 ALK+ lung cancer
Thank you for sharing your story, Allison!

Inspired by Allison's story?

Share your story, too!


More ALK+ Lung Cancer Stories

Stephanie K. ALK+ lung cancer

Stephanie K., Non-Small Cell Lung Cancer, ALK+, Stage 4 (Metastatic)



Symptoms: Persistent and intense cough, general feeling of sluggishness

Treatments: Chemotherapy, targeted therapy through a clinical trial, radiation therapy
Ruchira A. ALK+ stage 4 lung cancer

Ruchira A., Non-Small Cell Lung Cancer, ALK+, Stage 4 (Metastatic)



Symptoms: Mild intermittent cough while talking, low-grade fever, severe nonstop cough, coughing up blood, collapsed left lung​

Treatments: Surgery (lobectomy), targeted therapy
Laura R. ALK+ lung cancer

Laura R., Non-Small Cell Lung Cancer, ALK+, Stage 4 (Metastatic)



Symptoms: Persistent cough, fatigue, bone pain

Treatments: Targeted therapies (tyrosine kinase inhibitors or TKIs, including through a clinical trial)
Shauna D. stage 4 ALK+ lung cancer

Shauna D., Non-Small Cell Lung Cancer, ALK+, Stage 4 (Metastatic)



Symptom: Persistent dry cough following a cold
Treatments: Targeted therapy (tyrosine kinase inhibitors), radiation therapy
Allison Z. stage 4 ALK+ lung cancer

Allison Z., Non-Small Cell Lung Cancer, ALK+, Stage 4 (Metastatic)



Symptom: Severe back pain
Treatments: Targeted therapy (ALK inhibitors), radiation therapy

Categories
ALK Lung Cancer Non-Small Cell Lung Cancer Patient Stories Radiation Therapy Targeted Therapy Treatments

From Foot Pain to Lung Cancer: Kathrin’s Unexpected Stage 4 ALK+ Diagnosis

From Foot Pain to Lung Cancer: Kathrin’s Unexpected Stage 4 ALK+ Diagnosis

When Kathrin was diagnosed with stage 4 ALK+ lung cancer in 2024, it came as a complete shock. She didn’t have a cough, chest pain, or shortness of breath — none of the symptoms you’d expect. Instead, it all started with subtle signs: persistent fatigue, frequent illness, and a lingering pain in her left foot that she chalked up to an injury.

Interviewed by: Nikki Murphy
Edited by: Katrina Villareal

Being a fitness professional, Kathrin assumed it was nothing serious, but after the pain worsened, an MRI revealed something unexpected: a tumor in her foot. Initially thought to be benign, the biopsy showed it was a malignant metastasis. From there, a full-body PET/CT scan uncovered the real culprit: stage 4 ALK+ lung cancer, which had already spread to her bones, abdomen, and liver.

Kathrin W. stage 4 ALK+ lung cancer

Despite the shock and the immediate fear of not surviving, biomarker testing provided a silver lining. Kathrin was ALK-positive, making her eligible for targeted therapy. Treatment began with radiation on her foot, followed by a daily ALK inhibitor pill. Within weeks, the treatment produced remarkable results.

Kathrin’s scans looked almost clear, which felt like being handed back her life. She describes this part as surreal, going from imagining death to being filled with hope. While the physical treatment has gone well, the emotional part has been more complex. Even though the cancer was under control, the reality of living with an incurable condition remains. She knows it may come back, so she consciously chooses to focus on what she can control: her mindset, her movement, and her moments of joy.

Exercise has been Kathrin’s anchor. Even during radiation, she kept moving. For her, movement isn’t just fitness; it’s therapy. It’s how she reconnects with herself, processes her emotions, and taps into her inner strength. She emphasizes the importance of staying active, not just for the body but for mental clarity and emotional balance.

Her story highlights a powerful truth: stage 4 ALK+ lung cancer doesn’t always look like what we expect, especially in women. Kathrin’s experience is a reminder of the importance of advocating for your health, listening to your body, and honoring your strength, even when life throws something unimaginable your way.

Watch Kathrin’s full interview to learn more about her story:

  • She had no cough, just foot pain. That’s how her stage 4 ALK+ lung cancer was discovered.
  • Kathrin opens up about the emotional whiplash of a sudden diagnosis.
  • How yoga and exercise became her daily lifeline through stage 4 ALK+ lung cancer.
  • Why Kathrin believes powerful treatments and positivity can change everything.

  • Name: Kathrin W.
  • Age of Diagnosis:
    • 44
  • Diagnosis:
    • Lung Cancer
  • Staging:
    • Stage 4
  • Mutation:
    • ALK+
  • Symptoms:
    • Weakness
    • Decline of performance in sports
    • Depression
    • Pain in left foot
  • Treatments:
    • Radiation therapy
    • Targeted therapy
Kathrin W. stage 4 ALK+ lung cancer
Kathrin W. stage 4 ALK+ lung cancer
Kathrin W. stage 4 ALK+ lung cancer
Kathrin W. stage 4 ALK+ lung cancer
Kathrin W. stage 4 ALK+ lung cancer
Kathrin W. stage 4 ALK+ lung cancer
Kathrin W. stage 4 ALK+ lung cancer

This interview has been edited for clarity and length. This is not medical advice. Please consult with your healthcare provider to make informed treatment decisions.

The views and opinions expressed in this interview do not necessarily reflect those of The Patient Story.


Kathrin W. stage 4 ALK+ lung cancer
Thank you for sharing your story, Kathrin!

Inspired by Kathrin's story?

Share your story, too!


More ALK+ Lung Cancer Stories

Stephanie K. ALK+ lung cancer

Stephanie K., Non-Small Cell Lung Cancer, ALK+, Stage 4 (Metastatic)



Symptoms: Persistent and intense cough, general feeling of sluggishness

Treatments: Chemotherapy, targeted therapy through a clinical trial, radiation therapy
Ruchira A. ALK+ stage 4 lung cancer

Ruchira A., Non-Small Cell Lung Cancer, ALK+, Stage 4 (Metastatic)



Symptoms: Mild intermittent cough while talking, low-grade fever, severe nonstop cough, coughing up blood, collapsed left lung​

Treatments: Surgery (lobectomy), targeted therapy
Laura R. ALK+ lung cancer

Laura R., Non-Small Cell Lung Cancer, ALK+, Stage 4 (Metastatic)



Symptoms: Persistent cough, fatigue, bone pain

Treatments: Targeted therapies (tyrosine kinase inhibitors or TKIs, including through a clinical trial)
Shauna D. stage 4 ALK+ lung cancer

Shauna D., Non-Small Cell Lung Cancer, ALK+, Stage 4 (Metastatic)



Symptom: Persistent dry cough following a cold
Treatments: Targeted therapy (tyrosine kinase inhibitors), radiation therapy
Allison Z. stage 4 ALK+ lung cancer

Allison Z., Non-Small Cell Lung Cancer, ALK+, Stage 4 (Metastatic)



Symptom: Severe back pain
Treatments: Targeted therapy (ALK inhibitors), radiation therapy

Categories
Chemotherapy Clinical Trials Lung Cancer Patient Stories Targeted Therapy Taxol (paclitaxel) Treatments

Shirley’s Stage 4 Lung Cancer Story

Shirley’s Metastatic Lung Cancer Story

Interviewed by: Nikki Murphy
Edited by: Chris Sanchez

At age 34, Shirley, a translator from Southern California, faced the unexpected news that she had stage 4 lung cancer with an ALK mutation.

Shirley’s journey began in 2021, during the height of the COVID-19 pandemic, with a persistent cough that refused to go away despite multiple rounds of antibiotics and testing. Her doctors reassured her it was likely a minor infection, even though her symptoms grew to include severe back pain. Finally, a CT scan revealed a mass, but doctors still downplayed the likelihood of cancer due to her young age and history. Initially undiagnosed, she faced months of additional procedures, including 2 bronchoscopies and a wedge resection surgery. Only after extensive testing did she receive the staggering news: she had adenocarcinoma, initially suspected to have originated elsewhere in her body. Despite various scans showing otherwise, she spent weeks fearing widespread cancer.

Determined to take control, Shirley switched hospitals, explored different insurance options when she got married to her longtime boyfriend, and underwent chemotherapy. The side effects were brutal, including severe hair loss, swallowing difficulties, and infections that required hospitalization. Finally, genetic testing revealed she had an ALK mutation, allowing her to switch to a targeted therapy in pill form, providing 2 years of relative stability and an improved quality of life. Then, in 2023, the cancer began progressing again, necessitating further procedures and consultations. When her initial targeted therapy became ineffective, Shirley bravely enrolled in a clinical trial for a 4th-generation ALK inhibitor in July 2024. This new medication has had minimal side effects, with her tumor currently stable. Although she initially hesitated to join a clinical trial, Shirley realized its promise and now appreciates the thorough monitoring and regular scans.

Living with an incurable cancer has profoundly affected Shirley’s outlook on life. “It feels like I have a bomb inside of me,” she says, expressing the constant awareness of her tumor’s presence. With humor as her coping mechanism, Shirley shares darkly comedic memes and gives villain names to her tumor. Her husband and fellow cancer patients have become her pillars of support, as she finds comfort and laughter within her community of ALK patients, appreciating the unique understanding they bring.

Despite the trials of cancer, Shirley finds solace in sharing her experience, including on her Instagram, to help others. Her advice to newly diagnosed patients is heartfelt: avoid over-Googling statistics and connect with others who understand the cancer journey. “You’re not a statistic,” she insists. “See yourself as an individual.”

Shirley’s journey is one of resilience and transformation, where she now cherishes connections and purpose. By sharing her story, she aims to support others, proving that even amid uncertainty, there is value in embracing life with hope and humor.


  • Name:
    • Shirley M.
  • Diagnosis:
    • Lung cancer
  • Staging:
    • Stage 4
  • Initial Symptoms:
    • Persistent cough
    • Wheezing
    • Back pain
    • Shortness of breath
  • Treatment:
    • Chemotherapy
    • Targeted therapy
    • Radiation

This interview has been edited for clarity and length. This is not medical advice. Please consult with your healthcare provider to make informed treatment decisions.

The views and opinions expressed in this interview do not necessarily reflect those of The Patient Story.


Thank you for sharing your story, Shirley!

Inspired by Shirley's story?

Share your story, too!


Related Cancer Stories

More Lung Cancer Stories
Stephanie K. ALK+ lung cancer

Stephanie K., Non-Small Cell Lung Cancer, ALK+, Stage 4 (Metastatic)



Symptoms: Persistent and intense cough, general feeling of sluggishness

Treatments: Chemotherapy, targeted therapy through a clinical trial, radiation therapy
...
Jennifer M. EGFR-positive lung cancer

Jennifer M., Lung Cancer, EGFR+, Stage 4 (Metastatic)



Symptoms: None per se; discovered during physical checkup for what seemed to be a sinus infection

Treatments: Radiation therapy (stereotactic body radiation therapy or SBRT), targeted therapy
...
Laura R. ALK+ lung cancer

Laura R., Non-Small Cell Lung Cancer, ALK+, Stage 4 (Metastatic)



Symptoms: Persistent cough, fatigue, bone pain

Treatments: Targeted therapies (tyrosine kinase inhibitors or TKIs, including through a clinical trial)
...
Ashley C. stage 4 HER2+ lung cancer

Ashley C., Non-Small Cell Lung Cancer, HER2+, Stage 4 (Metastatic)



Symptoms: Fatigue, breathlessness, persistent back pain, multiple rounds of bronchitis

Treatments: Chemotherapy, targeted therapy
...
Loryn F. stage 4 HER2 lung cancer

Loryn F., Non-Small Cell Lung Cancer, HER2+, Stage 4 (Metastatic)



Symptoms: Extreme fatigue, persistent back pain, chest pain, joint pain in the feet, hips, legs, shoulders, and elbows

Treatments: Chemotherapy, radiation therapy (foot and elbow to help with mobility), antibody-drug conjugate
...
Clara C. metastatic lung cancer

Clara C., Lung Cancer, MSH6, Stage 4 (Metastatic)



Symptoms: Pelvic pain, joint and bone pain, breast lump, extreme lightheadedness and dizziness, vomiting, fainting spells, swollen lymph node in the neck, neuropathy, headaches, unexplained weight loss, severe anemia
Treatments: Radiation therapy to the brain, chemotherapy, immunotherapy
...